1. Home
  2. IVDA vs SPRC Comparison

IVDA vs SPRC Comparison

Compare IVDA & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iveda Solutions Inc.

IVDA

Iveda Solutions Inc.

N/A

Current Price

$0.29

Market Cap

3.7M

Sector

Technology

ML Signal

N/A

Logo SciSparc Ltd.

SPRC

SciSparc Ltd.

N/A

Current Price

$5.08

Market Cap

3.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IVDA
SPRC
Founded
2003
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7M
3.3M
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
IVDA
SPRC
Price
$0.29
$5.08
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.4M
37.8K
Earning Date
05-12-2026
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
51.38
N/A
EPS
N/A
N/A
Revenue
$4,468,279.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
132.98
N/A
52 Week Low
$0.21
$0.46
52 Week High
$2.24
$15.79

Technical Indicators

Market Signals
Indicator
IVDA
SPRC
Relative Strength Index (RSI) 45.80 33.41
Support Level $0.27 $3.95
Resistance Level $0.34 $7.40
Average True Range (ATR) 0.03 0.42
MACD -0.00 -0.20
Stochastic Oscillator 25.08 5.08

Price Performance

Historical Comparison
IVDA
SPRC

About IVDA Iveda Solutions Inc.

Iveda Solutions Inc offers smart city technologies globally, offering AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products). Geographically, the company operates in USA and Taiwan, majority of its revenue is generated from Taiwan.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: